Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups

scientific article published in July 2001

Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1215/S1522851700000569
P932PMC publication ID1920611
P698PubMed publication ID11465395

P2093author name stringDavis FG
Kupelian V
McCarthy B
Freels S
Surawicz T
P433issue3
P921main subjectUnited States of AmericaQ30
brain tumorQ233309
P304page(s)152-158
P577publication date2001-07-01
P1433published inNeuro-OncologyQ15724471
P1476titlePrevalence estimates for primary brain tumors in the United States by behavior and major histology groups
P478volume3

Reverse relations

cites work (P2860)
Q33824448A heritable predisposition to pituitary tumors
Q52646455A highlight on Sonic hedgehog pathway.
Q35877187A population based perspective on children and youth with brain tumours
Q37690203A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures
Q38104320A retrospective audit of 200 cases of CNS tumours and their surgical management in a tertiary care centre
Q36312901Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents
Q48686376Care and support needs of patients and carers early post-discharge following treatment for non-malignant brain tumour: establishing a new reality
Q30440459Caring for the brain tumor patient: family caregiver burden and unmet needs
Q38383345Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery
Q38238267Clinical trials in neurosurgical oncology
Q36236776Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010.
Q37240292De novo induction of genetically engineered brain tumors in mice using plasmid DNA
Q35794213Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007
Q34028148Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux
Q54749494Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature.
Q39927406Effect of hypoxia-inducible factor-1alpha silencing on the sensitivity of human brain glioma cells to doxorubicin and etoposide
Q36640218Effect of photodynamic therapy combined with torasemide on the expression of matrix metalloproteinase 2 and sodium-potassium-chloride cotransporter 1 in rat peritumoral edema and glioma.
Q35914897Emerging insights into the molecular and cellular basis of glioblastoma
Q38183762Epidemiology and etiopathogenesis of pituitary adenomas
Q88802580Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database
Q38131489Exploitation of adaptive evolution in glioma treatment
Q39192804Factors Associated With Pre- and Postoperative Seizures in 1033 Patients Undergoing Supratentorial Meningioma Resection.
Q34388280High-resolution mechanical imaging of glioblastoma by multifrequency magnetic resonance elastography
Q36736698Histological and Demographic Characteristics of the Distribution of Brain and Central Nervous System Tumors' Sizes: Results from SEER Registries Using Statistical Methods
Q28389877Incidental findings found in "healthy" volunteers during imaging performed for research: current legal and ethical implications
Q41462909Innate immune functions of microglia isolated from human glioma patients
Q39796091Leptin and its receptor are overexpressed in brain tumors and correlate with the degree of malignancy
Q30697362Low-grade gliomas
Q38366240Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain
Q30368396Meningiomas and Proteomics: Focus on New Potential Biomarkers and Molecular Pathways.
Q30356126Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
Q48743716Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas
Q36000273Overexpression of IL-7 enhances cisplatin resistance in glioma
Q55107585Posterior fossa medulloblastoma in an atypical extra-axial location: A case report.
Q34132943Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology
Q35225270RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
Q52685559Salvage therapy outcomes for atypical meningioma.
Q35772513Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time
Q35750188Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
Q37266716The Study of MIB-1 LI and CD 34 As A Marker of Proliferative Activity and Angiogenesis in Different Grades of Meningioma
Q44004603The detection of CMV pp65 and IE1 in glioblastoma multiforme
Q34915671The risks and benefits of searching for incidental findings in MRI research scans
Q41779891The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
Q30382505The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis
Q48166892Thymic CD8+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality
Q48204130Treatment of childhood astrocytomas with irinotecan and cisplatin.
Q64119164Vemurafenib Treatment of Pleomorphic Xanthoastrocytoma in a Child With Down Syndrome
Q90443047WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema

Search more.